GLS-010 Monotherapy Versus Chemotherapy in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma (R/R cHL)

Clinical trial NCT05518318 · UNKNOWN

Trial details

NCT number: NCT05518318
Sponsor: Guangzhou Gloria Biosciences Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Classic Hodgkin's Lymphoma Recurrent Classic Hodgkin Lymphoma Refractory Classic Hodgkin Lymphoma

Start date: 2022-09-01
Primary completion: 2025-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.